Company Overview and News

0
Gujarat NRE Coke Limited - Updates

2018-07-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
512579 GUJNRECOKE 570003 GUJNREDVR

0
Gujarat NRE Coke Limited - Updates

2018-07-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
512579 GUJNRECOKE 570003 GUJNREDVR

0
Gujarata NRE Coke proposes to repay ₹2,961 crore over 20-year period

2018-06-19 livemint
Kolkata: After failed attempts to liquidate Gujarat NRE Coke Ltd, Arun Kumar Jagatramka, promoter and chairman of the delinquent metallurgical coke-maker, is seeking a 20-year lifeline to turn profitable.
512579 GUJNRECOKE 570003 GUJNREDVR

0
Gujarat NRE Coke Limited - Shareholders meeting

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
512579 GUJNRECOKE 570003 GUJNREDVR

0
Gujarat NRE Coke Limited - Shareholders meeting

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
512579 GUJNRECOKE 570003 GUJNREDVR

0
NCLT asks Gujarat NRE Coke promoters to prepare new scheme to repay creditors

2018-05-15 livemint
Kolkata: In a first, the Kolkata bench of the National Company Law Tribunal (NCLT) has allowed the promoters of Gujarat NRE Coke Ltd, a delinquent company that owes around Rs4,600 crore, to draw up a new scheme to repay creditors after the official liquidator failed to find a taker.
512579 GUJNRECOKE 570003 GUJNREDVR

9
Lenders, bidders for IBC cases looks to keep employees happy

2018-04-12 livemint
Mumbai: Noting the key role of employees in companies undergoing bankruptcy proceedings, lenders and bidders are paying extra attention to ensure resolution plans take care of their interest to avoid any disruption in operations.
500470 570003 512579 GUJNRECOKE TTST TATASTEEL 521070 TATLY BHUSANSTL ALOKTEXT GUJNREDVR 500055

0
Gujarat NRE Coke Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
512579 GUJNRECOKE 570003 GUJNREDVR

0
Gujarat NRE chairman proposes new scheme to repay debt

2018-04-09 livemint
Kolkata: Arun Kumar Jagatramka, chairman and managing director of Gujarat NRE Coke Ltd, has moved the Kolkata bench of the National Company Law Tribunal (NCLT) proposing a new scheme for repaying creditors after an administrator failed to find takers for the metallurgical coke maker as a going concern, or a company in operation.
512579 GUJNRECOKE 570003 500141 FERROALL GUJNREDVR

0
Gujarat NRE Coke Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
512579 GUJNRECOKE 570003 GUJNREDVR

0
Gujarat NRE Coke Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
512579 GUJNRECOKE 570003 GUJNREDVR

1
Defer Binani Cement’s resolution process, Braj Binani group tells NCLT

2018-03-23 livemint
Kolkata: The Braj Binani group on Thursday asked the Kolkata bench of the National Company Law Tribunal (NCLT) to suspend the ongoing resolution process of group firm Binani Cement Ltd, even as one of the stakeholders said that the sanctity of the bankruptcy resolution process is now at stake.
BINANIIND 512579 GUJNRECOKE 570003 DALMIABHA 533309 UCLQY UCLQF 532538 500059 GUJNREDVR ULTRACEMCO

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...